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ABSTRACT
Contamination of combat trauma wounds with environmental residues can lead to
bacterial infection of orthopedic fractures, which causes delay and difficulties in patient
treatment. The reported infection rate of the improvised explosive devices (IED) injuries
is 91%, and biofilm formation on orthopedic implants can lead to chronic infection with a
rate of 40% in fracture wounds. Designing orthopedic implants that can self-regulate local
infection and biofilm formation is beneficial for these patients. Polytetrafluoroethylene
(PTFE) and biodegradable chitosan with local antibiotic (vancomycin) elution were
deposited on the stainless steel and titanium implant samples (coupons) to reduce biofilm
formation and bacterial infection. Staphylococcus aureus is the most common pathogen
associated with orthopedic implant infections. S. aureus Seattle 1945 (ATCC 25923) strain
was used to evaluate the antimicrobial and anti-biofilm properties of the modified metal
coupons using methods such as crystal violet analysis, ultrasound water bath with viable
cell counts and confocal laser scanning microscopy. The release rate of vancomycin from
the coupons was determined by HPLC analysis of collected leachates from surface
modified coupons. In vitro studies of antibacterial properties of the coupons showed that
PTFE did not provide significant advantages against biofilm formation, but the
incorporation of chitosan and vancomycin onto modified surfaces prevented biofilm
formation on the coupons. Local drug-release profile of antibiotic doped chitosan showed
the concentration of local vancomycin released within the first 48 hours was effective in
preventing bacterial attachment onto the coupons.
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CHAPTER 1
INTRODUCTION
Biofilm consists of a group of microorganisms attached to a surface within an
extracellular polymeric substance (EPS) matrix. Biofilm-associated cells have reduced
growth rate and different genes expression than their planktonic cells. Attachment is a
complex process and is influenced by different environmental factors and surface
characteristics. When the biofilm structure is established, the microorganisms inside it are
resistant to various antimicrobial agents. Biofilm formation on orthopedic implants after
surgeries is a major problem in the treatment of the patients. It delays the healing process
and revision surgeries might be needed to remove the implants with biofilm. Application
of surface modified implants with antimicrobial properties can limit bacterial colonization
on the implants. The first aim of this study is to characterize the antimicrobial properties
of surface modified implants. The combination of polytetrafluoroethylene (PTFE) and
chitosan with vancomycin as implants coating should enhance the antimicrobial properties
of the implants significantly. We hypothesize that the deposition of PTFE and
biodegradable chitosan with local antibiotic elution will enhance the functionality of the
implant surface for fixation and bacterial resistance. In order to characterize the biofilm
formed on the modified and unmodified surfaces to determine the best surface treatment in
terms of preventing biofilm formation, three different quantification methods were utilized.
Staphylococcus aureus encoding intracellular GFP was used to evaluate the viability,
colonization, and biofilm formation on modified and unmodified metal coupons via crystal
violet staining, laser confocal microscopy and viable cell count methods. Protocols for
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cultivation and quantification of biofilms on stainless steel (SS) and titanium (Ti), both
unmodified and modified, surfaces were developed and validated. In Aim two, the release
rates of chitosan and vancomycin were quantified by measuring the concentrations of
antimicrobial agent in the leachates of modified surfaces via HPLC. The antimicrobial
properties of modified coupons will be further validated in future in vivo rabbit models.

2

CHAPTER 2
BACKGROUND
2.1. Combat Trauma
Combat trauma is principally distinguished by deep, penetrating injuries that can be
contaminated with environmental and ballistic residues. The greatest threat to U.S. soldiers
sent into the current U.S. wars is combat-related injuries. These war wounds are mostly
open and exposed to environmental dirt and contaminants, so there is a considerable risk
of infection for these patients. The infection risk of these injuries is relatively high. Up to
40% of war-trauma patients are affected while in non-war-trauma patients the infection
risk is relatively low (Mody, et al. 2009). The infection rate of the improvised explosive
devices (IED) injuries is 91%. Infection in the fracture site can cause biofilm formation on
the implant surface, which is a severe problem in the treatment of these wounds. Biofilm
formation on orthopedic implants may lead to chronic infection, delayed fracture union and
revision surgeries (Mody, et al. 2009), which is a serious health problem for the patients
and will add to the treatment costs significantly.

2.2. Implants/DCP
Metal internal fixation including dynamic compression plate (DCP) systems are usually
used to treat long bone fractures, and are very common in blast injuries (Korzinek 1999),
(Giannoudis 2006). Colonization and adhesion of bacteria like Staphylococcus aureus (S.
aureus) and Staphylococcus epidermidis (S. epidermidis) on implant surfaces can cause
biofilm formation. Designing implants that could prevent local infection and biofilm
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formation at the fracture site will decrease the treatment time and healthcare costs for these
patients (Belt 2001), (van Loosdrecht 1990). Implants have been developed to improve
fracture healing, but it has also been found that they have a different susceptibility to
infection (Moriarty 2010). Implant infection has been reported to be one of the reasons for
orthopedic implant removal (Le 2014). Limiting the initial microbial adhesion to implant
surfaces is critical to defend against early infection (Raphel 2016). Application of nonadhesive surfaces on the implants is one strategy to reduce bacterial attachment. Implant
surface coatings such as polyethylene glycol (PEG) has significantly reduced S. aureus
adhesion (Yang 2005). Dextran is another coating polymer that has been reported to reduce
S. aureus and S. epidermidis adhesion by 50% (Zhang 2008). The effects of PTFE coating
on biofilm formation will also be evaluated in this thesis project. Applying anti-adherent
coatings alone may allow the bacteria to return, while bactericidal coatings can eliminate
the bacteria and prevent future infection (Raphel 2016). Therefore, the combination of antiadherent surfaces with bactericidal compounds can be more effective. Silver coated
implants and chitosan coatings alone or along with other antimicrobial compounds are the
most effectively used coatings on implant surfaces (Raphel 2016). Silver has been known
to have wide antimicrobial activities (Eckhardt 2013). Chitosan is also a bactericidal
polymer that has been combined with other antimicrobial compounds to increase its effects
(Ordikhani 2014). Chitosan and vancomycin have been applied on PTFE grafts (Parker
2013), but a combination of PTFE surface coating with chitosan and vancomycin has not
been studied before.
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2.3. Biofilm
Biofilm is a group of microorganisms in which cells stick together on a surface; these
adherents are attached within a self-produced matrix of extracellular polymeric substances
(EPS). These EPS usually consist of extracellular DNA, proteins, and polysaccharides.
Biofilm was first described by Antonie van Leeuwenhoek as the accumulation of
microorganisms in dental plaque in 1686. He is well known for his ability to build
microscopes and one of the early scientists to study microscopic life (Slavkin 1997). The
special three-dimensional structure of biofilm provides an environment for the bacteria to
live as a group of microorganisms together that can form on different living and non-living
surfaces in industry, hospitals and natural environments (P. K. Watnick 2000). Presumably
this structure serves as protection for microorganisms from the environment and host body
to increase their chances of survival. The microorganisms inside this structure will be
resistant to antibiotics. They are also protected from the host immune defense (Costerton
2005), (Darouiche 2004). Biofilms can also grow in nutrient conditions that do not permit
the growth of planktonic cells and bacterial growth rate is decreased in the biofilm structure
(P. R. Watnick 2000).

2.4. Biofilm Formation Stages
Biofilm development has different steps. The first one is the initial attachment. In
Staphylococcus aureus, the microbial surface components recognizing adhesive matrix
molecules (MSCRAMMS) are expressed, that help the bacteria to attach to different
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surfaces. The exact attachment mechanism is not known yet, but in the presence of these
molecules, the attachment is facilitated (C. T. Heilmann 2003). Polysaccharide intercellular
adhesion (PIA) with the chemical composition of poly-N-acetylglucosamine (PNAG) is
the main molecule responsible for intercellular adhesion. De-acetylation of Nacetylglucosamine in PIA positively charges the molecule, so PIA attaches by electrostatic
interaction to the bacterial surface that is normally negatively charged because of its
teichoic acids (Sadovskaya 2005). The ica gene locus is responsible for the production of
PIA molecules (Boles 2005). The next step is the maturation phase, which is known by
extracellular aggregation of adhesive proteins and polysaccharides with biofilm structural
forces that make three-dimensional mushroom-like cell towers and fluid-filled channels
between the towers through which nutrients are delivered to deeper biofilm cells. The exact
mechanism of this structure forming is not well known yet, but primary findings show the
role of the cell to cell signaling by quorum sensing which controls surfactant peptides to
build the biofilm structure (Boles 2005). Whenever the cell density is low, the adhesion
factors like MSCRAMMs are up-regulated and after colonization of the bacteria, the
expression of these molecules are decreased (Boles 2005). The final phase is the dispersal
phase, which leads to dissemination of the bacteria to new infection sites (Otto 2008).
Single cells or large cell clusters may detach from the biofilm surface area, which is also
controlled by the quorum sensing in staphylococci. The five stages of biofilm maturation
are shown in Figure 1.
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Figure 1. The five stages of biofilm maturation, 1) initial attachment; 2) irreversible
attachment; 3) maturation I; 4) maturation II; 5) dispersion (Monroe 2007)

2.5. Mechanisms of Biofilm Resistance
Four possible mechanisms of biofilm antibiotic resistance have been described. The
first mechanism is poor antimicrobial penetration in which antimicrobial agents penetrate
slowly or incompletely through the biofilm. Consumption of the antimicrobial agents by
the biofilm as it consumes other substrates will decrease the concentration of the
antimicrobial agents to a level that would be ineffective in the deeper regions of the biofilm
(P. S. Stewart 1996). The second mechanism of biofilm protection is stress response
defenses that are induced by biofilm-forming bacteria when they encounter an
environmental challenge (J. D. Chambless 2006). It has been suggested that slow growth
of bacterial cells in the biofilm is due to a general stress response that changes the cells
physiologically, so they will be protected from environmental stresses and detrimental
agents (Mah 2001). Altered microenvironment and slow growth is the third mechanism by
which bacteria in a biofilm are more resistant to antimicrobial agents. Within the biofilm
there is a micro-gradient found in the concentration of key metabolic substrates and

7

products. This leads to slow growing or stationary phase of bacterial cells when they are
less susceptible than the bacteria in the growing phase and enables them to survive
antibacterial challenges (Wimpenny 1995), (Gilbert 2003). The fourth mechanism of
antimicrobial resistance of biofilm is the possibility of a highly protected phenotype of
microorganism in a biofilm. Cells in this special state are called persisters (J. D. Chambless
2006). It seems likely that a combination of these factors determines the overall protection
of the biofilm. Mechanisms of biofilm tolerance are shown a cross-section of a biofilm
(Figure 2). The attachment surface is shown in grey. Yellow phase contains the antibiotic
at the top, where antimicrobial penetration is restricted in the presence of EPS. In the green
areas, some bacteria change their activity in response to antimicrobial stress. The
microenvironment in the deeper area is altered to resist eradication (pink). Persister cells
are present in higher concentration in biofilm (violet) (J. D. Chambless 2006).

Figure 2. Four possible mechanisms of biofilm antibiotic resistance (J. D. Chambless
2006).
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2.6. Factors Affecting Biofilm Formation
Biofilms can form on many different surfaces such as living tissues, medical devices,
industrial or natural aquatic systems. The ideal environment for the attachment of
microorganisms onto a surface is the solid-liquid interface between that surface and a liquid
medium like water or blood. The characteristics of the solid surface can also be important
in the attachment process. Surface roughness is one of the surface characteristics that affect
microorganism’s colonization, the surface area is higher on rough surfaces, and it appears
that colonization increases when the surface roughness increases. Surface hydrophobicity
can also play a role in the initial attachment; many studies showed that microorganisms
attach faster to hydrophobic, nonpolar surfaces such as Teflon and plastics than hydrophilic
surfaces like glass or metals (Donlan 2002) (Nurioglu 2015). The results of these studies
are contradictory because of the other variables that are always present in biofilm formation
and lack of standard methods to evaluate surface hydrophobicity. The liquid medium has
characteristics like pH, nutrient level, ionic strength and temperature that affects the
attachment of the microorganisms. Seasonal changes affecting biofilm formation in
aqueous systems might be ascribed to differences in temperature. A laboratory study also
demonstrated more microbial attachments when nutrient concentrations are higher (Otto
2008). Cell surface properties like hydrophobicity, fimbriae and flagella and EPS
production can influence the attachment rate. Most bacteria studied are negatively charged
and contain hydrophobic surface components (Donlan 2002). Different bacterial strains
might vary in hydrophobicity, and some studies did not find a relationship between the
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hydrophobicity of the bacterial surface and the extent of initial binding to either a
hydrophilic or hydrophobic substrate (N. P. Cerca 2005).

2.7. Gene Transfer in Biofilm
Biofilms provide a good environment for transferring of the extrachromosomal DNA
(plasmids) through conjugation as the cells in the biofilm are closer and cell-to-cell contact
is more possible. These plasmids may encode for resistance to antimicrobial compounds
(Donlan 2002).

2.8. Staphylococcus aureus
The majority of biofilm-associated infections are caused by Staphylococci, which is
the most common bacteria on the human surfaces like skin and mucous, and therefore can
easily enter the body through surgical cuts or infect the medical devices that enter these
surfaces (Otto 2008). Staphylococcus is a gram-positive, round shape, non-motile
facultative anaerobe bacterium that can grow without the need for oxygen. It is a member
of Firmicutes and normal body flora (Masalha 2001). It has grape-like clusters under the
microscope and produces large, round, golden-yellow colonies and does not form spores
(Ryan, Medical microbiology 2004), (Figure 3 - Figure 5). Staphylococcus aureus is a
ubiquitous bacterial species and it often exhibits hemolysis when grown on blood agar
plates (Ryan, Medical microbiology 2004). Alexander Ogston identified Staphylococcus
for the first time in 1880 in surgical pus in Scotland. Binary fission is the way that S. aureus
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reproduces asexually; the daughter cells remain attached to one another and appear as
clusters (Varrone JJ 2014). Staphylococcus can cause many diseases from mild skin
infections to serious, life-threatening infections. S. aureus is one of the most common
causes of hospital-acquired infections and the most common pathogen associated with
orthopedic implant infections (Ribeiro 2012). Staphylococcus aureus can produce a
multilayered biofilm embedded within a glycocalyx or slime layer. It is an important
clinical pathogen due to its resistance to antibiotics. The mortality rate of 25% infection
associated with S. aureus has been reported in the US (Belt 2001). It is the main cause of
osteomyelitis or infection of the bone. S. aureus Bacteria can enter through the blood or
direct inoculation during surgery, trauma or an old or chronic infection (Archer 2011).
Application of antimicrobial compounds to resolve the S. aureus infection is not effective
in most cases (Archer 2011). Preventing biofilm formation or removing formed biofilm by
surgery are the practical options to solve this issue. S. aureus strain Seattle 1945GFP is
used for evaluation of colonization, and biofilm formation on modified and unmodified
implant surfaces. Staphylococcus aureus subsp. aureus ATCC 25923 with the designation
Seattle 1945 is a clinical isolate that is used as a standard laboratory testing control strain.
It is sensitive to a variety of antibiotics, including methicillin (Treangen 2014). This
bacterium contains green fluorescent protein (GFP), which makes it possible to use
fluorescent microscopy to exam the presence and growth of bacteria and evaluate the
biofilm formation.
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Figure 3. SEM image of Staphylococcus aureus clusters (Carr. 2012)

Figure 4. Laser confocal image of Staphylococcus aureus clusters
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Figure 5. Staphylococcus aureus colonies on TSB plate (left) and S. aureus colonies on
an agar plate (right) (HansN. 2012)

2.9. PTFE
PTFE is a synthetic fluoropolymer of tetrafluoro ethylene, which has many industrial
and clinical applications. It is a high molecular weight hydrophobic compound made of
carbon and fluorine. It has been frequently used as a coating for surgical interventions like
catheters as it is non-toxic and biocompatible, while also possessing the ability to interfere
with the bacterial adhesion (Pavithra 2008). It has been shown that biofilm formation is
reduced when PTFE was applied as an anti-adherent coating. PTFE provides an antiadherence, microbe repelling surface and has been used in medical implants (Berry 2000),
(A. E. Demling 2010). PTFE structure is shown in Figure 6.
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Figure 6. PTFE structure (Nurioglu 2015)

2.10. Chitosan
Chitosan is a biopolymer (linear polysaccharide) composed of N-acetyl-2-amino-2deoxy-d-glucopyranose and 2-amino-2-deoxy-d-glucopyranose. Chitosan can be produced
commercially by deacetylation of chitin, the exoskeleton of crustaceans (such as crabs and
shrimp) and fungi cell walls. It is a non-toxic, biocompatible biomaterial that has been
shown to have antimicrobial properties against planktonic microbes (Rabea 2003), (Şenel
2004). The exact anti-microbial mechanism of chitosan is not clear yet (Carlson 2008), but
some possible mechanisms have been studied. There are different theories to explain
chitosan’s antimicrobial mechanism. More likely, chitosan’s anti-microbial mode of action
is not limited to a single target molecule. It has been shown that the initial contact between
the polycationic chitosan and negatively charged cell wall polymers leads to disruption of
the equilibrium of cell wall dynamics. In addition, binding of chitosan to cell wall polymers
could trigger secondary cellular impacts that destabilize and disrupt bacterial membrane
function leading to cellular components leakage and dysfunction of the whole cellular
system (Raafat 2008). As the resistance of chitosan-coated surfaces to biofilm formation
by S. aureus has been reported, using chitosan would provide a flexible platform for
designing coatings to protect implant surfaces from infection (Carlson 2008). When the
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active primary amino groups on the molecule are reactive, sites for a variety of side group
attachments are provided. Chitosan can be degraded by enzymes that can hydrolyze
glucosamine–glucosamine,

glucosamine–N-acetyl-glucosamine

and

N-acetyl-

glucosamine–N-acetylglucosamine linkages. The amino group in chitosan has a charge
density dependent on pH which makes it a bioadhesive that binds to negatively charged
surfaces. Chitosan biodegradation plays a role when it is applied to drug delivery systems.
This potential can be utilized as a carrier for controlled release of various therapeutic
compounds such as antibiotics (Dash 2011). Chitosan structure is shown in Figure 7.

Figure 7. Chitosan structure (Dash 2011)

2.11. Vancomycin
Vancomycin is an antibiotic used to treat several bacterial infections especially for
treatment of serious, life-threatening infections by gram-positive bacteria unresponsive to
other antibiotics (González 1999). Vancomycin is produced by soil bacterium
Amycolatopsis orientalis. It is a type of glycopeptide antibiotic and works by blocking the
proper biosynthesis of the cell wall in Gram-positive bacteria and a few of gram-negatives.
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Peptidoglycan layer of the cell wall is rigid because of its cross-linked structure consists of
N-acetyl muramic acid (NAM) and N-acetyl glucosamine (NAG) monomers. Vancomycin
binds to the NAM and NAG building blocks and inhibits cross-linking of peptidoglycan
layers. Because of that, the peptidoglycan layers will be less rigid and more permeable
leading to leakage of cellular contents and death of the affected bacteria (Watanakunakorn
1984). Vancomycin has been shown to be effective against Staphylococcus aureus (C. B.
Liu 2011). The in vivo half-life of vancomycin is 4-6 hours, and it is removed via renal
extraction (Bratzler 2005). The approximate half-life of vancomycin in vitro at 37°C is 9
days (White 1988), and the saturation limit of vancomycin is 17 mg/ml in solutions with
pH of 7.5 (Faustino 2008). These are some of the vancomycin parameters that need to be
considered when designing the experiments. Vancomycin structure is shown in Figure
8Error! Reference source not found..
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Figure 8. Vancomycin structure (C. B. Liu 2011)

2.12. Combination of PTFE, Chitosan and Vancomycin in Implant Design
The combination of PTFE and chitosan with vancomycin as implants coating would
increase antimicrobial properties of the implants significantly. We propose that the
deposition of polytetrafluoroethylene (PTFE) and biodegradable chitosan with local
antibiotic elution will enhance the functionality of the implant surface for fixation and
bacterial resistance.

2.13. Biofilm Quantification
In order to compare different surface treatments of orthopedic implants, standard
quantification methods are needed. There are different methods to quantify biofilms on
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solid surfaces in vitro, They can be divided into three main groups; microscopic methods,
cultural based procedures and biochemical investigations (K. K. Doll 2016). Each different
method has its advantages and disadvantages and therefore can be used for different
purposes. Six most popular quantifying methods to analyze biofilm of S. aureus bacteria
are listed as follows: CLSM, sonication and CFU, enzymes and CFU, resazurin, BacTiterGlo™ and crystal violet. (K. K. Doll 2016). In BacTiter-Glo™ method equal volumes of
PBS and the BacTiter-Glo™ reagent are added to the sample with biofilm. Followed by 5
min incubation at ambient temperature, and luminescence is measured using a multi-mode
reader. This method has been reported to be costly, but not time consuming (K. K. Doll
2016). Adding resazurin solution (a fluorescent dye) in PBS to the samples and incubating
at 37 °C is another biochemical method to analyze the biofilm. Fluorescence is then
measured using a multi-mode reader. This method is not costly and not time consuming
(K. J. Doll 2016). For a rapid high-throughput screening of antibacterial approaches, the
viability assays resazurin and BacTiter-Glo™ are very suitable. Application of enzyme to
detach bacteria followed by CFU counting is another quantifying method of biofilm. This
method is time consuming and moderately costly (K. K. Doll 2016). Crystal violet (CV)
staining, a low cost, not complicated and fast method for analysis of biofilm, was first
described by Christensen et al. (G. Christensen 1985). CV is a basic protein dye that binds
to negatively charged surface molecules and polysaccharides in the extracellular matrix (Li
2003). CV stains both live and dead cells as well as the matrix so it can not be used to
evaluate functional biofilm (Pitts 2003). The method is basically based on staining the
biofilm formed on a surface with CV, then rinse a few times to remove non-attached
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bacterial cells, wash with 95% ethanol to release the CV and then recording the optical
density (OD) with a spectrometer (Z. L. Xu 2016). Confocal laser scanning microscopy
(CLSM) is a technique for taking high-resolution optical images. As it can provide zsectioning of thick specimens, it is a suitable method for analyzing thickness, biomass and
structure through the 3D images or cross-sectional views of the biofilm. It has been used
extensively to increase the understanding of biofilm characteristics (Mueller LN 2006).
Development of the new analytical methods and software increased the quantitative output
of these images (Mueller LN 2006). COMSTAT is a program that enables the
quantification of the biofilm based on CLSM images. COMSTAT source code is used to
read the “tif” images based on the number of pixels in the image columns and rows and the
z-step size. An automatic threshold is used in MATLAB to separate the bacteria and surface
sequences (Ross 2014, Heydorn A1 2000). Sonication and viable cell count is another
method used to analyze biofilm formed on the implants. It is more complicated and timeconsuming than crystal violet method, but less costly and faster than laser confocal
microscopy (N. P. Cerca 2004), (C. G.-R. Heilmann 1996). The method is based on
recovering the live bacteria from the surface biofilm by detaching them through a
sonication technique followed by plate counting(CFU) method (K. J. Doll 2016). The lowmoderate sonication power (20-40 kHz) for a brief time (2-10 minutes) of bacterial
suspension in the water bath, has been shown to have the optimum effect on bacterial
detachment. Longer exposure time or more ultrasound power leads to disruption of the
bacterial cell wall (E. Joyce 2011), (Geir Bjerkan 2009). Based on the accessibility, cost
and required time each method, crystal violet, LCSM and Sonication with viable cell count
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were the three methods used in this study to quantify biofilm formed on the different
sample treatments.

2.14. MIC Determination
MIC is the lowest concentration of an antimicrobial, antibiotic or bacteriostatic drug
that inhibits the visible growth of a microorganism after overnight incubation. It is different
than the minimum bactericidal concentration (MBC), which is the concentration resulting
in microbial death (Tripathi 2013). The MIC of a compound is determined by preparing
solutions of the compound at constantly increasing concentrations in a series of tubes and
incubating the solutions with the cultured bacteria separately for 24 hrs. The turbidity of
the solutions indicates the amount of microbial growth, and no bacterial growth is when
the solution is clear. When the concentration of the antimicrobial compound increases the
turbidity of the solution decreases until the concentration reaches the MIC, that is, when
the microorganism cannot grow at or above that concentration. Minimum inhibitory
concentration of chitosan and vancomycin need to be determined in this study as we need
to apply the concentration more than the MIC in order to prevent bacterial growth and
subsequent biofilm formation on the implants.

2.15. Vancomycin Release Rate Determination
Chitosan is a biodegradable compound that is used as a carrier molecule for controlledrelease of vancomycin from the surface of the implants. Monitoring the release rate of
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vancomycin helps us to have a proper understanding of the effects of surface modifications
and track the antibacterial activities of the implants through time. High-performance liquid
chromatography (HPLC) is the method used in this study to determine the release rate of
vancomycin. An in vitro elution method by placing the disks in water and collecting the
leachates at different time periods and analyzing with HPLC to determine the concentration
of released vancomycin is a common method that has been used previously in different
studies (Hsu 2014), (Oyaert 2015), (Abu Tariq 2010).

2.16. Selection of the Implant Type
Based on the different biofilm quantification methods and the results of vancomycin
release rate, the best implant surface treatment is determined and will be evaluated in vivo
in a rabbit fracture model.
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CHAPTER 3
MATERIALS AND METHODS
3.1. Titanium and Stainless-Steel Round Shape Coupons
Stainless steel, titanium, and titanium alloys (titanium with 6% aluminum and 7%
niobium, TAN) are the most common materials used for fracture fixation implants (Hayes
2010). In this study biofilm was grown on different titanium and stainless-steel coupons
with aluminum in different particles sizes (90 µm and 50µm) coated with PTFE chitosan
and vancomycin that have been tested for their antimicrobial properties. The surface
modifications evaluated were alumina blasting (50 and 90 µm particle-size) with
CoBlasted PTFE and chitosan. The coupons dimensions are 1 cm diameter and 1mm
height. Stainless steel and titanium surfaces for bacteriostatic and biofilm regulation in
vitro was quantified. Different surface treatments including: stainless-steel (S), titanium
(T), Alumina in different particle sizes (5 for 50 and 9 for 90 µm particle-size), PTFE (P),
chitosan (X) and Vancomycin (V) have been prepared. Sample types and their
characteristics are listed in Table 1. The metal coupons’ shape and design is illustrated in
Figure 9.
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Table 1. List of coupon materials and their characteristics

Sample
ID
SB
SA5C
SA9C
SP5C
SP9C
SBX
SP5CX
SP9CX
SBV
SP5CV
SP9CV
TB
TA5C
TA9C
TP5C
TP9C
TBX
TP5CX
TP9CX
TBV
TP5CV
TP9CV

Base Material
StainlessTitanium
Steel
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50
90
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µm
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Figure 9. Metal coupons

3.2. Bacterial Strain
For quantification the growth of biofilm on the stainless-steel and titanium sample
coupons, a methicillin-susceptible Staphylococcus aureus strain Seattle 1945 (ATCC
25923) was used. A clinical isolate, that is used as a standard laboratory testing control. This
bacterium contains green fluorescent protein (GFP), thus presence, growth and
colonization of bacteria can be evaluated using fluorescent microscopy.

3.3. Bacterial Growth on the Coupons
Staphylococcus aureus ATCC 2593 stock cultures were streaked on Tryptic
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Soy Agar (TSA) +1% glucose plates and incubated overnight at 37°C to obtain isolated
colonies. A single colony was transferred to Tryptic Soy Broth (TSB) media and grown
overnight in a shaker incubator at 37°C and 125 rpm to the concentration around 1x109
CFU/ml inoculum. The overnight cultures were used to inoculate the experimental
coupons. Stock cultures were frozen in 1:1 of 20% sterile glycerol and media. Bacteria
were recovered in 10 ml of media and incubated for 24 h at 37°C.

3.4. Coupon Cleaning Procedure
Prior to use, coupons were cleaned and sterilized. Individual coupons were soaked in a
70% Ethanol solution for 10 minutes and then washed in 1x Phosphate buffered saline
(PBS) solution, then soaked in ethanol solution and rinsed with PBS again and left in sterile
petri dishes to dry.

3.5.Coating the Underside (Unmodified) Surface of the Coupons with VALAP
Since only one side of each metal coupon was modified, i.e., co-blasted, biofilm growth
on the unmodified side of the coupons needed to be minimized. The coating of the
unmodified surfaces of each coupon with VALAP, a biologically inert material consists of
vaseline, lanolin and paraffin wax in equal ratio, that has been shown to prevent bacterial
attachment (Jung 2014), was further optimized to ensure that only the biofilm form on the
modified surfaces were quantified.
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3.6. Cultivation and Quantification of Biofilm
Cultivation and quantification of biofilm growth on metal coupon surfaces were
conducted as follows; briefly, 24-well flat-bottom non-tissue-culture treated microtiter
plates were used to minimize binding of bacteria onto the wells and to facilitate the
cultivation of biofilm on metal coupon surfaces. Coupons were dipped gently into the
melted VALAP until the bottom side was covered. Each coupon was then placed into a
separate well of the 24-well plate. 600 µl of TSB+1% glucose was added to each well to
cover the entire surface of the coupon. The concentration of the overnight S. aureus was
determined using a Bio-Rad SmartSpec 3000 spectrophotometer and 103 bacterial cells
were added to each well containing coupon and the plate was kept in an incubator at 37°C
for 24 hours. Washing of metal coupons after growth of biofilms was by dipping the
coupons in wells containing 500 µl of D.I. water. This process was repeated 3 times to
wash away planktonic bacteria. The biofilms on metal coupons were then observed using
an epi-fluorescence microscope or a laser confocal microscope. For quantification of
biofilm, the crystal violet staining method or viable cell count experiment was used. A
positive control, i.e., a well-containing TSB and bacterial inoculum, and a negative control,
i.e., a well-containing TSB without bacteria were included for each individual experiment.
Cultivation of bacterial biofilm on metal coupons is shown in Figure 10.
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Figure 10. Cultivation of bacterial biofilm on metal coupons

3.7. Quantification of Biofilm Via Crystal Violet Staining
For quantification of biofilm growth on metal coupons using crystal violet method, they
were processed as follows: After the last wash to remove unbound planktonic cells, the
coupons were placed into empty wells and allowed to air-dry at 37C for 30 minutes. Metal
coupons were placed into wells containing 600 µl of 0.1% (w/v) aqueous crystal violet
solution and stained for 5 minutes at room temperature. The metal coupons were then
washed 3 times in wells containing 600 µl of D.I. to remove excess stains and air-dried at
37C for 30 minutes. 600 µl of 100% ethanol was added to the wells containing coupons
to dissolve the bound crystal violet and the plate was placed on a shaker (50 rpm) at room
temperature for 10 minutes to detach the adherent biofilm growing on the coupons. 100 µl
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of each solution was transferred into a 96-well microtiter plate and the biofilm quantified
using a Synergy H1 Hybrid Microplate Reader reading at 590 nm. A typical result of crystal
violet stained biofilm on the metal coupons is illustrated in Figure 11.

Figure 11. A typical crystal violet stained biofilm cultivated on the surface of metal
coupons, A. Inoculated; B. Control

3.8. Quantification of Biofilm Using Confocal Laser Scanning Microscopy (CLSM)
The fluorescence property of S. aureus Seattle 1945GFPuvr strain was verified using a
Zeiss laser confocal microscope (Figure 12). Confocal laser scanning microscopy (CLSM)
is a technique for obtaining high-resolution optical images with depth selectivity (Z stacks).
The main feature of confocal microscopy is its ability to acquire in-focus images from
selected depths. Washing metal coupons after the growth of biofilms is completed by
dipping the coupons in wells containing 600 µl of D.I. water. This process is repeated 3
times to wash away planktonic bacteria. The biofilms on metal coupons then observed
using an epi-fluorescence microscope or a laser confocal microscope. Images acquired
point-by-point and reconstructed with the computer, allowing three-dimensional
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reconstructions of topologically complex objects. Three-dimensional images gave us a (an
idea) view of biofilm structure on different surface treatments. Interpreting the images
through measuring some features of bacterial biofilm using COMSTAT software gave us
the ability to determine the best surface material and treatment of the disks that can prevent
or reduce biofilm formation on the metal implants.

Figure 12. Confocal laser scanning microscopy

The fluorescence property of S. aureus Seattle 1945GFPuvr strain was verified using a
Zeiss laser confocal microscope and the result illustrated in Figure 13 and Table 2.
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Figure 13. Microscopic views of S. aureus Seattle 1945GFPuvr strain. A. fluorescence
microscopy; B. bright field microscopy; C. superimposed images.
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Table 2. Microscopic Examination of S. aureus Seattle 1945GFPuvr Biofilms on Metal
Coupons. The top-view images were both at 200x. The side-view images were laser
confocal stacked images.
Epi-fluorescence Microscopy

Laser Confocal Microscopy

(Top Views)

(Side Views)

Metal Coupon

Titanium

Stainless Steel

To analyze the biofilm distribution on coupon surfaces, wide-field fluorescence images
were taken using Nikon AZ100 epi-fluorescence microscope and the images were analyzed
using the ImageJ software (Figure 14). The signal thresholds, e.g., optimized brightness
and saturation settings were standardized in all image acquisition and analysis.
Thresholding was applied with manual adjustment. Threshold limits were maintained at a
constant value for all the images (Carson 2010), (Rasband 1997-2007).

31

Figure 14. AZ100 microscopy and a wide-field fluorescent image of biofilm on metal
coupon

3.9. Biofilm Thickness and Biomass Analysis
To analyze the average thickness and biomass of biofilm formed on coupon surfaces,
multiple laser confocal image stacks were analyzed using the COMSTAT software. The
image acquisition and data analysis were standardized and optimized, e.g., size of
inoculum, incubation time, and the number of stacks. There are some features that are
calculated by COMSTAT; Bio-volume, which is defined as the number of biomass pixels
in all images of a stack multiplied by the voxel size [(pixel size) x× (pixel size) y× (pixel
size) z] and divided by the substratum area of the image stack. The resulting value is
biomass volume divided by substratum area (µm3/µm2). Bio-volume represents the overall
volume of the biofilm, and provides an estimate of the biomass in the biofilm. Area
occupied by bacteria in each layer: This is the fraction of the area occupied by biomass in
each image of a stack and the substratum coverage is the area coverage in the first image
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of the stack. Substratum coverage reflects how efficient is the colonization of bacteria on
the substratum. Thickness distribution and mean thickness: This function locates the
highest point (µm) above each (x,y) pixel in the bottom layer containing biomass. Hence,
the thickness is defined as the maximum thickness over a given location, ignoring pores
and voids inside the biofilm. Mean biofilm thickness provides a measure of the spatial size
of the biofilm and is the most common variable used in biofilm literature (Russ 2016).

3.10. Quantification of Biofilm Using Viable Cell Count Method
A viable count test was performed to quantify biofilm formation on the coupons since
this method yields more consistent and sensitive results than the crystal violet method. We
followed the Bjerkan method with modification; Briefly, after cultivation of biofilm on the
coupon surface, each disk was placed into a 15ml sterile conical tube containing 5ml of
PBS and gently vortexed for 15 seconds to rinse off planktonic cells. After addition of 5ml
of PBS, each tube was then subjected to sonication for 5 minutes. This wash 1 solution
(W1) was serially diluted 10-1, 10-2, 10-3, and 10-4 folds. 100 µl from each undiluted and
diluted sample was plated on TSA and incubated at 37C for 48hr. Each disk was washed
a second time in 5ml PBS in ultrasound water bath for another 5 minutes yielding wash
solution W2. The washing process was repeated for the third time yielding W3. Viable
counts of W2 and W3 was conducted the same way described for W1. Numbers of colonies
were counted and the total cell number of each coupon was calculated (Bjerkan 2009). By
calculating the recovered bacterial cells from different treatments, we could compare the
surface treatments. Sonication and viable cell count experiments are shown in Figure 15.
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Figure 15. Sonication and viable cell count

3.11. Validation of the Methods
To validate the biofilm quantifying methods, round shape glass coverslips with 10 mm
diameter and 0.16-0.19 mm thickness were used with three different quantifying methods
including crystal violet, laser confocal and viable cell count as described for the metal
coupons. The results were obtained to determine if the methods utilized are reproducible
and consistent. The typical setups for biofilm quantification methods are shown in Figure
16 - Figure 18.

Figure 16. Glass round coverslips (left) and bacterial growth on glass coverslip (right)
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Figure 17. Validation of crystal violet experiment

Figure 18. Validation of viable cell count experiment
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3.12. Determination of the Minimum Inhibitory Concentration (MIC) of Chitosan
The MIC of chitosan was measured to determine whether the chitosan released from
the samples is sufficient to affect the bacterial biofilm formation. The experiment is mainly
preparing a series of two-fold dilutions of chitosan from high concentration to low in a 96well plate and then cultivate the bacteria in the wells, incubate them and observe the growth
in each well. The turbidity of each well determines whether the bacteria has grown or not.
Since the solubility of chitosan in water is low, chitosan was first dissolved in acetic acid
added to subsequent growth media for analysis. The MIC of acetic acid was determined
first in order to select an appropriate concentration of acetic acid that is not inhibitory when
used as a solvent for chitosan. Two-fold serial dilutions of acetic acid starting from 4M to
1mM solutions were prepared in 96-well plates using fresh liquid media as the diluents.
Each well was then seeded with 1x105 CFU of test bacteria. The plates were incubated
overnight at 37C and inspected the following morning. Acetic acid at sub-MIC (1/4 MIC)
concentration was used as the solvent for chitosan in subsequent experiments. Chitosan did
not easily dissolve in lower concentrations of acetic acid, so a more concentrated stock was
prepared first. 0.01g of chitosan powder was added to 200 μl of 0.5M acetic acid in a tube.
This tube was then put on a heat block for 30-60 minutes until the chitosan was fully
dissolved. However, once the chitosan was dissolved in the acid, the solution would be too
viscuse to pipette into different holders, so 2 ml of purified water was added to the solution,
and then the tube was placed back on the heat block until the solution became less viscuse.
Two-fold serial dilutions of chitosan was prepared after that, and added to a 96-well plate
in total volume of 200 μl for each well (100 μl of chitosan solution plus 100 μl of 2x media
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and 2x105 CFU/ml bacterial inoculum). There were two controls including the following:
one well filled with solution of the Cation-adjusted Mueller Hinton broth (CAMHB) media
with fresh bacteria, and one well filled with solution of just the CAMHB media without
bacteria. Once all the solutions were placed in the 96-well plate, it was placed in an
incubator for 24 hours to allow the bacteria to grow. The well plate was inspected after for
bacterial growth, and the data was recorded.

3.13. Determination of the MIC of Vancomycin
The MIC of vancomycin was measured to determine whether the vancomycin released
from the samples is sufficient to affect the bacterial biofilm formation. The experiment
entails mainly preparing a series of two-fold dilutions of vancomycin from high to low
concentration in a 96 well plate and then cultivate the bacteria in the wells, incubate them
and observe the growth in each well. The turbidity of each well determines if the bacteria
has grown or not. 0.01 gram of vancomycin powder was dissolved in 1 ml DI water, twofold serial dilutions of vancomycin solution were prepared after that, and added to a 96well plate in total volume of 200 μl for each well (100 μl of vancomycin solution plus 100
μl of 2x media and 2x105 CFU/ml bacterial inoculum). There were two controls including
the following: one well filled with a solution of the CAMHB media with fresh bacteria,
and one well filled with a solution of just the CAMHB media without bacteria. Once all
the solutions were placed in the 96-well plate, it was placed in an incubator for 24 hours to
allow the bacteria to grow. The well plate was inspected after for bacterial growth, and the
data was recorded.
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3.14. Vancomycin Release Rate Study
The release rate of vancomycin from the modified surfaces was evaluated to assess
whether the amount of vancomycin deposited on modified implant surfaces would be
sufficient to maintain the anti-biofilm property for 7 days. In one experiment, vancomycin
discs were tested for an entire week to determine if the amount of vancomycin remained
on the discs at different time periods was sufficient to prevent biofilm formation on the
coupons. The experimental design is as follows: seven (one for each day of a continuous
week) individual coupons (TBV type, TBV1-TBV7) were placed (one each) into individual
microtiter plate wells containing 600 µl of TSB medium plus 1% glucose. The well
containing disc TBV1 was immediately inoculated with 1000 Staph. aureus cells and
sealed to prevent evaporation of media. The amount of biofilm formed on disk one after 24
hrs. of incubation at 37° C was determined. Leachates from individual wells containing
coupons number 2-7 were removed after 24 hrs. and replaced with 600 µl of fresh TSB
medium and TBV2 was inoculated with 1000 Staph. aureus cells; the amount of biofilm
formed after the second 24 hrs. incubation at 37° C was determined for disk number 2,
Discs 3, 4, 5, 6, and 7 were processed the same way after 48, 72, 96, 120, and 144 hrs.,
respectively.

3.15. High-Performance Liquid Chromatography (HPLC) Analysis
To determine the release-rate of vancomycin and whether vancomycin contained in the
leachates from individual modified surfaces was sufficient to inhibit the growth of test
bacteria Staph. aureus, leachates from individual discs collected at different time points
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were analyzed for their vancomycin contents as follows: different vancomycin-surfacemodified discs were placed (one each) into microtiter plate wells containing 600 µl of TSB
medium with 1% glucose and sealed to prevent evaporation of media, at each 24-hour time
points, leachates were removed from each well for analyzing vancomycin content via
HPLC; 600 µl of fresh TSB was added back to each well and the same steps were repeated
a total of 7 days. For HPLC analysis a LC System; Shimadzu LCMS‐8040, Prominence
Series with ESI interface and autosampler was used. The Kinetix XB C18 (100 x 3mm,
2.6um) column was used, and the solvents were A:0.1% Formic Acid and B: Methanol, as
aqueous and organic solvents respectively. Certified standards were run to optimize the
method.

3.16. Statistical Analysis
IBM SPSS statistic software version 24 was used for statistical analysis. To analyze the
results of biofilm quantifying methods and the results of validating of the methods, a oneway ANOVA test is run with a Tukey post-hoc analysis. The one-way ANOVA test is used
to determine whether there are significant differences between the means of data.
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CHAPTER 4
RESULTS
4.1. Biofilm Quantification Results
The effect of PTFE+chitosan+vancomycin on stainless steel and titanium surfaces for
bacteriostatic and biofilm regulation in vitro was quantified. We validated that these
materials can be used to limit bacterial colonization of implant surfaces in vitro in a S.
aureus bacterial model. The viability of S. aureus cultivated in growth media on these
surfaces over time was quantified. The S. aureus biofilm formation on individual
modified/unmodified metal disk surfaces over time was quantified via crystal violet
staining, laser confocal microscopy, and viable cell count methods. Since only one side of
each metal coupon was modified, i.e., co-blasted, biofilm growth on the unmodified side
of the coupons needs to be minimized. The coating of the unmodified surfaces of each
coupon with VALAP was used in biofilm analysis, that has been shown to prevent bacterial
biofilm formed. VALAP was applied to ensure that only the biofilm formed on the
modified surfaces were quantified.

4.2. Crystal Violet Data
S. aureus Seattle 1945 formed biofilms on the surface of metal coupons. Crystal violet
dye has been utilized to stain bacterial biofilms. Stained biofilm was dissolved in ethanol
to recover the crystal violet for quantification using a microplate reader. The concentration
of crystal violet recovered is proportional to the amount of biofilm on metal surfaces. The
results of crystal violet staining are shown in Figure 19 - Figure 21. The experiment was
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performed in three replications for ten different surface treatments including, SB: stainless
steel disk; SA5C: 50µm CoBlast stainless steel; SA9C: 90µm CoBlast stainless steel;
SP5C: 50µm CoBlast-PTFE stainless steel; SP9C: 90µm CoBlast-PTFE stainless steel,
TB: titanium disk; TA5C: 50µm CoBlast titanium; TA9C: 90µm CoBlast titanium; TP5C:
50µm CoBlast-PTFE titanium; TP9C: 90µm CoBlast-PTFE titanium.

Figure 19. Crystal violet staining of the biofilm on the metal coupons
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Figure 20. Crystal violet OD590 of tested coupons for three sets of 10 different sample
types
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Figure 21. Crystal violet OD590 of tested stainless steel (SS) and titanium (TI) coupons for
three sets of sample types
Based on the collected data, no significant difference was observed among 10 different
treatments. It appears that titanium base materials exhibited better biofilm suppression than
stainless steel (Error! Reference source not found.).

4.3. Confocal Laser Scanning Microscopy Data
After bacterial growth on ten different modified surface coupons for 24 hours, the
coupons were washed three times with DI water to eliminate the unattached bacteria from
the surfaces. The coupons were then placed into glass bottom chambers upside down while
using glass coverslips as spacers to elevate the coupons thus preventing direct contact of
biofilms to the bottom of the chamber to avoid changing the biofilm structure. Images were
taken using CSLM with a 63x objective and oil immersion. For each coupon, 3 image
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stacks were taken. One typical image of Z stack series of the biofilm formed on the coupon
is shown in Figure 22, and Figure 23 shows a 3D structure of biofilm on the metal coupon
surface.

Figure 22. One series of Z stacks of the biofilm formed on the coupon

Figure 23. A 3D structure of biofilm on the metal coupon surface
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4.4. Biofilm Thickness and Biomass Analysis
To analyze the average thickness and biomass of biofilm formed on coupon surfaces,
multiple laser confocal image stacks were taken and analyzed using COMSTAT software.
The data is shown in Table 3.

Table 3. Wide-field fluorescence and laser confocal images
Disk Type

Images

Disk Type

SA5C

TA9C

SP5C

SP9C

TP5C

TP9C

SA9C

TA5C

SB

TB
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Images

To enumerate the average biofilm thickness and biomass on different coupon surfaces,
the wide-field fluorescence images taken using Nikon AZ100 epi-fluorescence microscope
were analyzed using the ImageJ software. The results are shown in Table 4.

Table 4. COMSTAT analysis of biofilm thickness and biomass
Sample Type

Average Thickness (µm)

Biomass (µm3/µm2)

SB

3.67705

1.88372

SA5C

9.00548

2.43798

SA9C

5.92908

3.64167

SP5C

1.437513

0.28256

SP9C

6.98783

1.75675

TB

5.73802

1.92333

TA5C

5.09406

1.22100

TA9C

5.18069

0.74439

TP5C

10.86349

2.35303

TP9C

8.39567

1.28102

From the collected data, different surface treatments showed different amounts of
biofilm formed on them. These results are based on one set of 10 different surface
treatments. No specific trend between the treatments was observed. In terms of preventing
biofilm formation, it seems that SP5C showed better results than the other sample types.
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There were less biofilm thickness and biomass observed on this sample type. The sample
type with the highest biofilm thickness observed was TP5C and the sample type with the
most biofilm biomass was SA9C.

4.5. Viable Cell Count Data
Evaluation of modified implant surfaces for their anti-biofilm properties was performed
by viable cell count method; Three sets of 22 different modified implant surfaces including
stainless steel and titanium with and without vancomycin deposition were tested. No
significant advantages against biofilm formation on any specific modified surfaces have
been observed EXCEPT those with vancomycin modified surfaces where no viable
bacteria were recovered. Viable counts of biofilm recovered from various surface-modified
stainless steel and titanium coupons for three complete sets are shown in Figure 24 and
Figure 25. Biofilms recovered on unmodified, 50µm CoBlast, 90µm CoBlast, 50µm
CoBlast-PTFE, 90µm CoBlast-PTFE, chitosan and vancomycin modified stainless steel or
titanium surfaces are consistent with previous reported results. In addition, no viable cells
were recovered from vancomycin modified stainless steel or titanium surfaces. Results
from low inoculum (103 cells per coupon) and short duration (24 hours) indicate that
chitosan modified surfaces do not provide any advantages in preventing biofilm formation
by S. aureus strain Seattle 1945. In order to assess whether chitosan modified surfaces
provide advantage in preventing biofilm formation during long-term-exposure, we
conducted a 7-day exposure study where titanium, chitosan-modified titanium and
vancomycin titanium coupons were incubated in growth media inoculated with 103 cells
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for 7 days. No significant difference in the number of cells recovered from the two coupon
types were observed. (Figure 26). For both experiments ANOVA analysis with SPSS
software of the collected data did not show significant difference between different surface
treatments (α=0.05).

Figure 24. Cultivation and quantification of biofilm on SS and Ti coupon surfaces by
viable cell count method
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Figure 25. Viable counts of biofilm recovered from three sets of 22 different metal
surface treatments in log scale
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Figure 26. Viable counts of biofilm recovered from three sets of three different metal
surface treatments after 7 days incubation time

4.6. Validation of the Methods
To validate the biofilm quantifying methods, round shape glass coverslips were used
with three different quantifying methods, i.e., crystal violet staining, laser confocal
microscopy and viable cell count as previously described for the metal coupons. These
experiments were conducted to determine whether the used methods are reproducible and
consistent in terms of analyzing the amount of biofilm formed on the coupons. Results are
showed in Figure 27 - Figure 32 and Table 5.
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Figure 27. OD results of crystal violet test for three glass coverslip samples and control
without bacteria
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Figure 28. OD results of crystal violet test for average of three glass coverslip samples
and control without bacteria
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Figure 29. One Z stack of LCSM of the biofilm formed on the glass coverslip

Table 5. COMSTAT analysis of biofilm thickness and biomass on glass coverslips
Sample Type

Average Thickness (µm)

Biomass (µm3/µm2)

Sample 1

3.87302

1.58352

Sample 2

3.28549

1.37056

Sample 3

4.90568

2.23520

Control

0

0
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Figure 30. COMSTAT analysis of biofilm thickness and biomass on glass coverslips
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Figure 31. Viable cell count results of three glass coverslip samples and control
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Figure 32. Average of viable cell count results of three glass coverslip samples and
control
To validate the consistency and reproducibility of the methods biofilm was grown on
the glass coverslips and analyzed using three quantification methods to evaluate biofilm
formed on the metal coupons. The results showed that the biofilm formed successfully on
the glass coverslips Figure 29. Quantification of biofilm formed on the glass coverslips
showed the consistency and reproducibility of the used methods. All the data falls within
the range of quantified biofilm of the metal coupons. In the crystal violet test the OD results
of three glass coverslips were in the range of (0.398333 - 0.525) with standard deviation of
0.065509. The viable cell count for total cells recovered from the glass coverslips result
fell within (7.59E+05 - 1.21E+06 cells) with standard deviation of 231902.7. CLSM data
showed the biofilm thickness range of (3.28549 - 4.90568 µm) and standard deviation of
0.820223, biomass evaluation of biofilm formed on the glass coverslips were within
(1.37056 - 2.2352 µm3/µm2) with standard deviation of 0.450489. All in all, the obtained
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data for each different method are close (based on small standard deviation that indicates
the data points are close to the mean, and 90% of the obtained data fall within the standard
deviation) and this demonstrates the consistency and reproducibility of the methods.

4.7. MIC Results
The MIC of chitosan against S. aureus Seattle 1945 has been determined to be 790
µg/ml, and the MIC of vancomycin against S. aureus Seattle 1945 has been determined to
be 1.22 µg/ml. A typical result of MIC test is shown in Figure 33.

Figure 33. A typical microtiter plate result of MIC test

4.8. Vancomycin Growth Inhibition Test and Release Rate
Since vancomycin modified surfaces exhibited significant anti-biofilm properties, we
evaluated the release rate of vancomycin from metal coupons to assess whether the amount
of vancomycin deposited on modified implant surfaces would be sufficient to maintain the
anti-biofilm property for 7 days. In one experiment, seven vancomycin discs of the same
type (TBV) were tested for 7 consecutive days to determine whether the amount of
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vancomycin remained on the discs at different time periods was sufficient at preventing
biofilm formation on the coupons.
Table 6. Viable cells recovered from vancomycin modified surface at each 24-hour time
points
Disc Type Time (hour) Viable Count (CFU)
TBV-1

0-24

Not detected

TBV-2

24-48

5.18E+05

TBV-3

48-72

2.59E+06

TBV-4

72-96

4.59E+05

TBV-5

96-120

4.26E+05

TBV-6

120-144

1.83E+06

TBV-7

144-168

5.01E+05

As shown in Table 6, the amount of vancomycin remained on TBV discs in the period
of 0-24 hours in 600 µl TSB media was sufficient in preventing biofilm formation on the
disc surface while the amount of vancomycin remained on TBV surfaces in the period of
24-48, 48-72, 72-96, 96-120, 120-144 and 144-168 hours was not sufficient in preventing
biofilm formation on the disc surface. To determine the release-rate of vancomycin and
whether vancomycin contained in the leachates from individual modified surfaces was
sufficient to inhibit the growth of test bacteria Staph. aureus, leachates from individual
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discs collected at different time points were analyzed for their antimicrobial properties and
vancomycin contents. Results are shown in Figure 34 and Table 7.

Figure 34. The antimicrobial property of leachates from 6 vancomycin-surface-modified
discs at different 24-hour time points

Table 7. The antimicrobial property of leachates from 6 vancomycin-surface-modified
discs at different 24-hour time points
Time/Disc Type

SBV

SP5CV

SP9CV

TBV

TP5CV

TP9CV

Day 1

No Growth

No Growth

No Growth

No Growth

No Growth

No Growth

Day 2

Growth

Growth

Growth

Growth

Growth

Growth

Day 3

Growth

Growth

Growth

Growth

Growth

Growth

Day 4

Growth

Growth

Growth

Growth

Growth

Growth

Day 5

Growth

Growth

Growth

Growth

Growth

Growth

Day 6

Growth

Growth

Growth

Growth

Growth

Growth

Day 7

Growth

Growth

Growth

Growth

Growth

Growth
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As shown in Table 7, the amount of vancomycin released from 6 different vancomycinmodified discs in the period of 0-24 hours into 600 µl TSB medium was sufficient in
preventing the growth of Staph. aureus inoculated while the amount of vancomycin
released during 24-48, 48-72, 72-96, 96-120, 120-144, 144-168 hours was not sufficient in
preventing the growth of Staph. aureus inoculated.

Table 8. Concentration of vancomycin released from six different vancomycin-modified
surfaces during a 7-day study

1

Time/Coupon Type

SBV

SP5CV

SP9CV

TBV

TP5CV

TP9CV

Day 1

10.997 (ppm)

4.904

7.886

5.180

7.921

4.841

Day 2

0.245

0.0595

0.098

0.087

0.102

0.123

Day 3

BDL1

BDL

BDL

BDL

BDL

BDL

Day 4

BDL

BDL

BDL

BDL

BDL

BDL

Day 5

BDL

BDL

BDL

BDL

BDL

BDL

Day 6

BDL

BDL

BDL

BDL

BDL

BDL

Day 7

BDL

BDL

BDL

BDL

BDL

BDL

Below Detection Limit
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As shown in Table 7, Table 8 and Figure 35, SBV appeared to release the highest
amount of vancomycin among the coupon types tested and the majority of vancomycin was
released during the first 24 hours.

12

ppm (µg/ml)

10
8
6
4
2
0
SBV

SP5CV

SP9CV

TBV

TP5CV

TP9CV

sample type
0-24 h

24-48 h

Figure 35. Vancomycin released from SBV coupon in the first and second 24 hours

As it is shown in Figure 35, most of vancomycin is released in the first 24 hours of
coupon exposure to the medium. So, coupons with thicker coatings of the chitosan and
vancomycin (five new variations) were fabricated in an effort to extend the release of
vancomycin. The amount of vancomycin deposited on the coupons was increased, but the
density of vancomycin within the co-deposited chitosan remained the same. The same
leachate experiments were conducted to see whether the release rate of the new
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vancomycin samples is different from the old samples. Based on the results of experiments,
we can conclude that vancomycin-modified surfaces exhibited the best anti-biofilm and
antimicrobial properties. However, the majority of vancomycin was released from the
modified surface during the first 24 hours. We have modified the vancomycin deposition
process to produce vancomycin-modified surfaces with higher concentration of
vancomycin and repeated the evaluation process to select for the final candidates for testing
in the animal models. Since vancomycin modified surfaces exhibited significant antibiofilm properties, we evaluated the release rate of vancomycin from to assess whether the
amount of vancomycin deposited on modified implant surfaces would be sufficient to
maintain the anti-biofilm property for 7 days. In our previous experiments, we observed
that most of the vancomycin in different sample types was released within the first 24
hours. In order to prolong the release of vancomycin and to enhance the antimicrobial
activity, implants modified with 1, 3, 6, 9, or 12 layers, and another one deposited under
high-power (HP) setting have been prepared and evaluated. We have examined the
vancomycin release rate of different TP5C samples coated with various layers of
vancomycin. During HPLC analysis of vancomycin TP5C samples with different layers of
vancomycin, we have learned that the TSB medium containing the vancomycin leachate
interact with the HPLC column matrix and interfere with the detection. The release rate of
vancomycin was repeated using water as the sample matrix. The results are shown in Table
9 and Figure 36.
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Table 9. Concentration of vancomycin released from different vancomycin-modified
TP5C surfaces with different layers of vancomycin during a 4-day study in water matrix

Day\Vancomycin layers

HP-5
1

3

6

9

12

Repetition

1

2

3

1

2

3

1

2

3

1

2

3

1

2

3

1

2

3

Day 1

9.55

11.33

7.56

19.91

16.58

17.87

16.43

19.42

28.62

74.645

70.01

77.57

96.21

79.395

119.415

41.155

74.58

37.94

Day 2

0.24

0.314

0.311

0.361

0.731

0.575

0.505

0.549

1.169

1.789

1.697

2.143

1.506

3.135

4.101

0.738

1.675

0.937

Day 3

0.116

0.141

0.146

0.148

0.142

0.135

0.137

0.146

0.172

0.179

0.172

0.171

0.191

0.238

0.209

0.156

0.218

0.156

Day 4

0.111

0.116

0.113

0.126

0.119

0.12

0.117

0.124

0.132

0.124

0.12

0.124

0.124

0.139

0.129

0.129

0.146

0.126

Sum

10.017

11.901

8.13

20.545

17.572

18.7

17.189

20.239

30.093

76.737

71.999

80.008

98.031

82.907

123.854

42.178

76.619

39.159

Based on the above analysis we can conclude that majority of the vancomycin on
different implant surface was released within the first 24 hours, 1, 3 and 6 layers are
significantly different from 9 and 12, but they are not significantly different from each
other and HP. 9 and 12 are not significantly different from each other and HP was just
significantly different from 12, but not from 1, 3, 6 and 9 layers. The amount of vancomycin
released from 9 and 12 layers within the second 24 hours was also considerable. ANOVA
analysis was done with SPSS software for different surface treatments (α=0.05).

59

Figure 36. Concentration of vancomycin released from TP5C vancomycin-modified
surfaces with different layers of vancomycin on the surfaces during a 4-day study, P ≤
0.05*
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CHAPTER 5
DISCUSSION
Biofilm formation on the surface of orthopedic implants can cause serious problems
for patients, especially for patients with war injuries as their wounds are open and biofilm
formation bacteria such as S. aureus, the most common pathogen associated with
orthopedic implant infections, can enter the body and establish biofilm structure on the
implant surface. Chronic infection, delay in the treatment, and revision surgeries to remove
the implant are problems that can be prevented if the biofilm formation is inhibited on the
implant surfaces. Once the biofilm is formed it becomes resistant to antibiotics. The
protective mechanisms in biofilms against antibiotics are not completely understood, but
are hypothesized to be influenced by reduced penetration ability due to biofilm structure,
nutrient limitation and slow growth, adaptive stress responses, and formation of persister
cells (P. S. Stewart 2002), (Høiby 2010). In this thesis work, application of PTFE for its
anti-adherent properties, chitosan for its antibacterial effects and its ability to act as a carrier
molecule for vancomycin was studied. PTFE coatings have been shown to reduce the
bacterial adhesion on medical devices in clinical studies (Berry 2000), (A. E. Demling
2010). In this study, we did not observe significant difference between PTFE coated and
non-PTFE coated surfaces. There are other studies with the same finding (Fuchslocher
Hellemann 2013). Although PTFE is a biocompatible, nontoxic compound that provides
a hydrophobic surface for clinical devices, some studies have shown that proteins adhere
quickly to PTFE surfaces (Müller 2009). There are proteins in the surface of the bacteria
and therefore they can attach to the PTFE surfaces. These results contradict with some
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clinical findings indicating that biofilm formation is reduced on anti-adherent PTFE coated
surfaces (A. E. Demling 2010). Our findings did not show any significant advantage of
PTFE coated surfaces in terms of biofilm prevention. This could be due to hydrophobic
characteristic of S. aureus bacteria (Reifsteck 1987), and since hydrophobic bacteria prefer
hydrophobic materials, application of PTFE in this case has a negative impact. The other
compound used in this study as the surface coating was chitosan, a biocompatible,
biodegradable natural polysaccharide with antibacterial properties. The MIC of chitosan in
this study was determined to be 790 µg/ml. Thus, the chitosan used should prevent bacterial
growth at this and higher concentrations. Results obtained from using different biofilm
quantifying methods in this study did not demonstrate any significant advantage of using
chitosan as a biofilm inhibitor. There are various factors that could influence the results.
The fact that chitosan is not water soluble and it dissolves in low concentration of acetic
acid (1.0M) while the in vitro studies were conducted in water-based TSB media thus, the
absence of significant biofilm inhibitory contributed by chitosan could be due to low its
solubility in test media. The other possibility is that the concentrations of chitosan on the
coupons were not enough to prevent bacterial growth in 600 µl of TSB media (our
experiments’ condition). It should be considered that chitosan was used as a carrier
molecule for the antibiotic as well. Vancomycin was the antibiotic used in this study, which
has been shown to be effective against Staphylococcus aureus (C. B. Liu 2011).
Vancomycin modified surfaces successfully prevented biofilm formation on the implant
surfaces. The results from three biofilm quantifying methods showed the complete
prevention of bacterial growth on the implant surfaces. LCSM scanning of the modified
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surfaces with vancomycin did not detect any GFP signal from these coupons, while for the
other surface treatments the biofilm formed all over the coupon surfaces. No bacterial cell
was recovered from the vancomycin treated surfaces. Crystal violet is a quick and simple
method best for initial analysis of the modified surfaces. It is sensitive to pipetting and
evaporation of the liquids and thus, not suitable when evaluation of higher number of
samples are needed, e.g., more than 10 samples. For 22 treatments and three replications
of each, keeping the experiment condition the same for all the samples became challenging
and not feasible. For these reasons, we switched to using viable cell count method in
subsequent experiments, which is a more accurate method for quantification of biofilms.
LCSM was the other method used to evaluate biofilm formation. This method enabled us
to exam the biofilm structures and biofilm characteristics such as biofilm thickness and
biomass. Although the accuracy of the LCSM method has been shown to be considerably
better, the problems lie in that it is both time-consuming and costly in comparison with the
other two methods. Minimum area of at least 100000 µm2 should be imaged to have
representative data of the biofilm formed on one surface (Heydorn 2000). Each stack area
is about 10000 µm2 and it takes 30 minutes to one hour to take the entire Z stacks for one
area. With at least 10 different stacks of each sample type to be imaged and 22 different
sample types to be evaluated, the required time to complete such task is considerable.
Therefore, the viable cell count method was the method of choice for completion of all
biofilm quantification analysis and the data was used in combination with the physical
property data for selection of the final surface-modified implants for in vivo studies in a
rabbit model. However, the number of sample types to be evaluated in animal study will
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be limited and LCSM would be a more suitable method of choice for analyzing the
recovered implants (explants). The MIC for chitosan for S. aureus has been reported in
range of 20 µg/ml to 1250 µg/ml (Shanmugam 2016). In this study, it is determined to be
790 µg/ml. We determined the vancomycin MIC to be 1.22 µg/ml, which is within the
range of previously reported vancomycin MIC for S. aureus (0.5µg/ml- 2 µg/ml) (Moise
2007).
The results of antimicrobial property test of the leachates from 6 vancomycin-surfacemodified discs at different 24-hour time points showed that the amount of vancomycin
released from 6 different vancomycin-modified discs in the period of 0-24 hours into 600
µl TSB medium was sufficient in preventing the growth of S. aureus inoculated while the
amount of vancomycin released during 24-48, 48-72, 72-96, 96-120, 120-144, 144-168
hours was not sufficient in preventing the growth of Staph. aureus inoculated. It is worth
noting that the localized release of vancomycin from implant surfaces into adjacent tissues
in vivo could potentially be higher. The release rate of vancomycin samples was tested in
vitro by collecting the leachates from different vancomycin surface treatments for one
week. HPLC analysis of the collected leachates showed that the majority of vancomycin
was released in the first 24 hrs. of coupon exposure to the medium. Therefore, coupons
with thicker vancomycin coatings were fabricated and evaluated (3, 5, 6, 9 and 12 layers).
The HPLC results of vancomycin samples with more vancomycin layers showed that the
majority of the vancomycin on different implant surface was released within the first 24
hours. 1, 3 and 6 layers are significantly different from 9 and 12, but they are not
significantly different from each other and HP (5 layers). 9 and 12 are not significantly
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different from each other and HP was just significantly different from 12, but not from 1,
3, 6 and 9 layers. The amount of vancomycin released from 9 and 12 layers within the
second 24 hours was also considerable. One of the aims of this study is to identify implant
core material with specific surface modification that could prevent biofilm formation. In
vitro analysis showed the combination of biodegradable chitosan and vancomycin is
successful in preventing biofilm formation in the first 24 hours. We also know that bacterial
attachment is an important stage of biofilm formation (Otto 2008), and the first 6 hours
after surgery are critical period for preventing early infection, as the introduced pathogens
have not yet begun rapid proliferation (Raphel 2016). The amount of vancomycin released
within the first and second 24 hours of the coupon exposure was enough to eliminate 1000
cells (bacterial inoculum used in the experiments) S. aureus bacteria in 600 µl TSB.
Culturing 100 µl of the leachates after 24 hours of inoculation with bacteria on TSA plates
did not show any growth of bacteria, indicating the bacterial cells could not survive in the
leachate after 24 hours. Based on data obtained from these in vitro studies, TB (as the
control), TBV and TA5CV each with 9 layers of vancomycin depositions were selected to
further evaluate their performance in vivo. The results obtained from in vivo studies in
rabbits will reveal the effectiveness of the chitosan plus vancomycin implant surface
coated.

5.1. Future Work
Based on different in vitro anti-bacterial analysis of the modified surfaces and other
factors and characteristics that affects biofilm formation on the implants, such as surface
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roughness, area, charge and hydrophobicity or hydrophilicity of the surfaces that will be
accessed by the bioengineering group, the best treatments will be selected for the animal
study. Overall, the goals are to determine the pre-clinical viability of optimized DCP
surfaces using short- and long-term in vivo bacterially-challenged rabbit fracture models.
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